Perindopril Erbumine

Product NDC: 68180-237
11-digit product format: 681800237
Labeler code: 68180
Product ID: 68180-237_fbb31482-9ac8-48c6-b814-5d467f22051b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Perindopril Erbumine
Dosage form: TABLET
Route: ORAL
Labeler: Lupin Pharmaceuticals, Inc
Application: ANDA078263
Marketing category: ANDA
Marketing start: 2010-03-15
Marketing end: 0000-00-00
Substance: PERINDOPRIL ERBUMINE
Active strength: 8 mg/1
Pharmacologic classes: Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	68180-237		I	Inactivated by FDA		2026-10-05
excluded package	package	68180-237	68180-237-01	I	Inactivated by FDA		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68180-237-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68180-237-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68180-237-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68180-237-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68180-237-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68180-237-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68180-237-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68180-237-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68180-237-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68180-237-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	68180-237-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	68180-237-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	68180-237-01	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	68180-237-01	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	68180-237-01	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	68180-237-01	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	68180-237-01	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	68180-237-01	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	68180-237-01	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	68180-237-01	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	68180-237-01	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	68180-237-01	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A078263-001	PERINDOPRIL ERBUMINE	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27
A078263-002	PERINDOPRIL ERBUMINE	PERINDOPRIL ERBUMINE	4MG	TABLET / ORAL	2010-01-27
A078263-003	PERINDOPRIL ERBUMINE	PERINDOPRIL ERBUMINE	8MG	TABLET / ORAL	2010-01-27

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A078263-001	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A078263-002	PERINDOPRIL ERBUMINE	4MG	TABLET / ORAL	2010-01-27	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A078263-003	PERINDOPRIL ERBUMINE	8MG	TABLET / ORAL	2010-01-27	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A078263-001	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078263-002	PERINDOPRIL ERBUMINE	4MG	TABLET / ORAL	2010-01-27	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A078263-003	PERINDOPRIL ERBUMINE	8MG	TABLET / ORAL	2010-01-27	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A078263-001	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078263-002	PERINDOPRIL ERBUMINE	4MG	TABLET / ORAL	2010-01-27	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A078263-003	PERINDOPRIL ERBUMINE	8MG	TABLET / ORAL	2010-01-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078263-001	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078263-002	PERINDOPRIL ERBUMINE	4MG	TABLET / ORAL	2010-01-27	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078263-003	PERINDOPRIL ERBUMINE	8MG	TABLET / ORAL	2010-01-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A078263-001	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078263-002	PERINDOPRIL ERBUMINE	4MG	TABLET / ORAL	2010-01-27	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A078263-003	PERINDOPRIL ERBUMINE	8MG	TABLET / ORAL	2010-01-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078263-001	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078263-002	PERINDOPRIL ERBUMINE	4MG	TABLET / ORAL	2010-01-27	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078263-003	PERINDOPRIL ERBUMINE	8MG	TABLET / ORAL	2010-01-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078263-001	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078263-002	PERINDOPRIL ERBUMINE	4MG	TABLET / ORAL	2010-01-27	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078263-003	PERINDOPRIL ERBUMINE	8MG	TABLET / ORAL	2010-01-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078263-001	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078263-002	PERINDOPRIL ERBUMINE	4MG	TABLET / ORAL	2010-01-27	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078263-003	PERINDOPRIL ERBUMINE	8MG	TABLET / ORAL	2010-01-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078263-001	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078263-002	PERINDOPRIL ERBUMINE	4MG	TABLET / ORAL	2010-01-27	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078263-003	PERINDOPRIL ERBUMINE	8MG	TABLET / ORAL	2010-01-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078263-001	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078263-002	PERINDOPRIL ERBUMINE	4MG	TABLET / ORAL	2010-01-27	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078263-003	PERINDOPRIL ERBUMINE	8MG	TABLET / ORAL	2010-01-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078263-001	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078263-002	PERINDOPRIL ERBUMINE	4MG	TABLET / ORAL	2010-01-27	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078263-003	PERINDOPRIL ERBUMINE	8MG	TABLET / ORAL	2010-01-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A078263-001	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A078263-002	PERINDOPRIL ERBUMINE	4MG	TABLET / ORAL	2010-01-27	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A078263-003	PERINDOPRIL ERBUMINE	8MG	TABLET / ORAL	2010-01-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078263-001	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078263-002	PERINDOPRIL ERBUMINE	4MG	TABLET / ORAL	2010-01-27	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078263-003	PERINDOPRIL ERBUMINE	8MG	TABLET / ORAL	2010-01-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078263-001	PERINDOPRIL ERBUMINE	2MG	TABLET / ORAL	2010-01-27	`301d65b070ca…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
b7225d76-59fc-c13f-c287-78d1c893ca87	Product name	2	20150206

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68180-237-01	2019-10-21	C162847	48780-1	956f9ecf-ca8f-621f-e053-dbdaa90a74ad	Perindopril Erbumine Tablets 2 mg, 4 mg and 8 mg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68180-237-01	Perindopril Erbumine	100 in 1 BOTTLE	TABLET	100		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
PERINDOPRIL ERBUMINE	ACTIVE INGREDIENT	1964X464OJ	PERINDOPRIL ERBUMINE TABLET [LUPIN PHARMACEUTICALS, INC]	1
PERINDOPRIL	ACTIVE MOIETY	Y5GMK36KGY	PERINDOPRIL ERBUMINE TABLET [LUPIN PHARMACEUTICALS, INC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	PERINDOPRIL ERBUMINE TABLET [LUPIN PHARMACEUTICALS, INC]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	PERINDOPRIL ERBUMINE TABLET [LUPIN PHARMACEUTICALS, INC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	PERINDOPRIL ERBUMINE TABLET [LUPIN PHARMACEUTICALS, INC]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	PERINDOPRIL ERBUMINE TABLET [LUPIN PHARMACEUTICALS, INC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68180-237	PERINDOPRIL ERBUMINE TABLET [LUPIN PHARMACEUTICALS, INC]	1	Legacy NDC, 1 package rows	20100315_fbb31482-9ac8-48c6-b814-5d467f22051b.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
1964X464OJ	PERINDOPRIL ERBUMINE	107133-36-8	PERINDOPRIL ERBUMINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
854984	perindopril erbumine 2 MG Oral Tablet	PSN	fbb31482-9ac8-48c6-b814-5d467f22051b	1
854988	perindopril erbumine 4 MG Oral Tablet	PSN	fbb31482-9ac8-48c6-b814-5d467f22051b	1
854925	perindopril erbumine 8 MG Oral Tablet	PSN	fbb31482-9ac8-48c6-b814-5d467f22051b	1
854984	perindopril erbumine 2 MG Oral Tablet	SCD	fbb31482-9ac8-48c6-b814-5d467f22051b	1
854988	perindopril erbumine 4 MG Oral Tablet	SCD	fbb31482-9ac8-48c6-b814-5d467f22051b	1
854925	perindopril erbumine 8 MG Oral Tablet	SCD	fbb31482-9ac8-48c6-b814-5d467f22051b	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
68180-237-01	68180023701	100 in 1 BOTTLE	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Perindopril Erbumine Tablets 2 mg, 4 mg and 8 mg	Lupin Pharmaceuticals, Inc \| Lupin Limited	2010-01-01	HUMAN PRESCRIPTION DRUG LABEL	1